Management of Negative and Low Hepatitis B Antibody Results

Understanding Anti-HBs Levels and Protection

Anti-HBs levels ≥10 mIU/mL are considered protective against hepatitis B virus (HBV) infection, as recommended by the Centers for Disease Control and Prevention (CDC) 1
Levels <10 mIU/mL after a complete vaccination series indicate inadequate protection and require revaccination, according to the Clinical and Molecular Hepatology guidelines 2, 1
Most non-responders (44-100%) will develop protective antibody levels after receiving a second complete three-dose vaccination series, as reported in the Clinical and Molecular Hepatology journal 2

Immunocompetent individuals with anti-HBs <10 mIU/mL after primary vaccination should receive a complete revaccination series, as recommended by the CDC 1
After revaccination, test anti-HBs levels 1-2 months after the final dose to confirm response, according to the CDC guidelines 1
If still no response after revaccination, test for HBsAg to rule out chronic infection, as suggested by the CDC 1

Healthcare workers, dialysis patients, immunocompromised individuals, and sexual partners of HBsAg-positive persons require post-vaccination testing 1-2 months after completing the vaccination series, as recommended by the Clinical and Molecular Hepatology and Hepatology guidelines 2, 3
Dialysis patients and immunocompromised individuals with anti-HBs <10 mIU/mL need booster doses and annual testing, according to the Clinical and Molecular Hepatology guidelines 2, 4
HIV-infected persons and other immunocompromised individuals may require more frequent monitoring of anti-HBs levels, as suggested by the CDC 1

For most individuals: Administer a complete 3-dose series (at 0, 1, and 6 months), as recommended by the Clinical and Molecular Hepatology and CDC guidelines 2, 1
For infants born to HBsAg-positive mothers with anti-HBs <10 mIU/mL: Give a single dose of HepB vaccine and retest 1-2 months later; if still <10 mIU/mL, complete the second series with two additional doses, according to the CDC guidelines 1
For healthcare workers with documented complete vaccination but anti-HBs <10 mIU/mL: Provide one additional dose followed by testing; if still <10 mIU/mL, complete with two more doses, as recommended by the CDC 1, 5

Persons exposed to HBV who have anti-HBs <10 mIU/mL should receive hepatitis B immune globulin (HBIG, 0.06 mL/kg) and hepatitis B vaccine as soon as possible, preferably within 24 hours, as suggested by the Clinical and Molecular Hepatology guidelines 2

Sexual partners of HBV carriers should be vaccinated if they test negative for HBV serologic markers, as recommended by the Hepatology guidelines 3, 6
Household contacts of HBV carriers should be tested and vaccinated if negative for HBV markers, according to the Hepatology guidelines 7, 6
Hepatitis A vaccination is recommended for HBV carriers who are negative for anti-HAV, as coinfection increases mortality risk by 5.6- to 29-fold, as reported in the Clinical and Molecular Hepatology journal 2, 8

The Centers for Disease Control and Prevention recommends that healthcare workers who received hepatitis B vaccination during childhood should have their anti-HBs level measured immediately, and if it is <10 mIU/mL, they should receive one additional dose of hepatitis B vaccine followed by retesting 1-2 months later 9
Antibody levels decline significantly over time, particularly in those vaccinated during infancy rather than adolescence, with protection persisting for ≥22 years in vaccine responders 10

The American College of Occupational and Environmental Medicine recommends measuring anti-HBs level using a method that detects levels ≥10 mIU/mL upon hire or matriculation for all healthcare workers with documented childhood vaccination 9
If anti-HBs ≥10 mIU/mL, no further action is needed, as the healthcare worker is considered protected, and no routine booster doses are required 9, 10

The Advisory Committee on Immunization Practices does not recommend more than two vaccine series in nonresponders, and after two complete series without response, the person should be considered a primary nonresponder and counseled about post-exposure prophylaxis needs 10, 11

The Centers for Disease Control and Prevention advises against assuming protection based solely on vaccination history, as documentation of a complete vaccine series does not guarantee current immunity 9
The Advisory Committee on Immunization Practices recommends against delaying testing until after an exposure, as pre-exposure testing and vaccination is far superior to relying on post-exposure management alone 9